Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 16:17:55 UTC, with 35 holding rows worth $131,607,387.

Accession
0001104659-26-127905
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 35 entries on the cover page, a total value of $131,607,387 stated on the cover page (in dollars after the unit check, H1), rows summing to $131,607,387 with VALUE read as dollars as filed, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PRAXIS PRECISION MEDICINES I74006W207COM NEW84,193$24,519,527dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN4,685,912$17,619,029dollars as filed
TANGO THERAPEUTICS INC87583X109COM409,529$10,217,749dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock535,109$7,657,410dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR5,558$5,329,622dollars as filed
ARRIVENT BIOPHARMA INC04272N102COM170,893$5,174,640dollars as filed
SURROZEN INC86889P208COMMON STOCK152,541$4,908,769dollars as filed
VOGENX INC92859A106COM213,186$4,858,509dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK93,152$4,640,833dollars as filed
OCULAR THERAPEUTIX INC67576A100COM574,543$4,406,745dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS393,583$4,301,862dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK691,843$3,369,275dollars as filed
AVALYN PHARMA INC05348Y105COMMON STOCK114,749$3,269,199dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK186,308$2,856,102dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock216,568$2,533,846dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK514,110$2,488,292dollars as filed
MINERVA NEUROSCIENCES INC603380205COM NEW729,500$2,443,825dollars as filed
LB PHARMACEUTICALS INC50180M108COMMON STOCK52,718$2,023,317dollars as filed
ACADIA PHARMACEUTICALS INC004225108COM1,000$2,015,000dollars as filedcall
ARTIVA BIOTHERAPEUTICS INC04317A107COM260,416$1,854,162dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM62,956$1,832,020dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock8,237$1,690,727dollars as filed
QUINCE THERAPEUTICS INC COM22053A305Stock52,918$1,640,987dollars as filed
ROIVANT SCIENCES LTDG76279101SHS41,535$1,518,935dollars as filed
DESIGN THERAPEUTICS INC25056L103COM115,392$1,450,477dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock2,240$1,213,834dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock89,826$1,205,465dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM87,918$1,184,255dollars as filed
ERASCA INC COM29479A108Stock67,541$990,151dollars as filed
AN2 THERAPEUTICS INC037326105COM142,051$755,711dollars as filed
ADIAL PHARMACEUTICALS INC00688A304COM NEW129,982$521,228dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK25,290$407,422dollars as filed
EQUILLIUM INC29446K106COM183,000$297,375dollars as filed
COMPASS THERAPEUTICS INC20454B104COM251,001$261,041dollars as filed
STOKE THERAPEUTICS INC86150R107COM5,771$150,046dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-127905this filing2026-11-16